Sort
23,748 grants matching “melanoma”
B-RAF Regulation of the Cell Cycle in Melanoma
$256,470Andrew E Aplin · Thomas Jefferson University · R01 · FY2010 · CA
PAK Kinases Regulate Melanoma Chemoresistance and Metastasis
$256,470Anand K Ganesan · University Of California-Irvine · R01 · FY2016 · CA
PAK Kinases Regulate Melanoma Chemoresistance and Metastasis
$256,470Anand K Ganesan · University Of California-Irvine · R01 · FY2015 · CA
ENHANCEMENT OF ANTI-TUMOR IMMUNITY BY INHIBITION OF TGF-B SIGNALING IN PATIENS WI
$256,461Richard A Flavell · Yale University · P50 · FY2007 · CA
ENHANCEMENT OF ANTI-TUMOR IMMUNITY BY INHIBITION OF TGF-B SIGNALING IN PATIENS WI
$256,461Richard A Flavell · Yale University · P50 · FY2009 · CA
ENHANCEMENT OF ANTI-TUMOR IMMUNITY BY INHIBITION OF TGF-B SIGNALING IN PATIENS WI
$256,461Richard A Flavell · Yale University · P50 · FY2008 · CA
ENHANCEMENT OF ANTI-TUMOR IMMUNITY BY INHIBITION OF TGF-B SIGNALING IN PATIENS WI
$256,461Richard A Flavell · Yale University · P50 · FY2010 · CA
Use of Adjuvants to Improve Skin Genetic Immunizations
$256,389Adriana T Larregina · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · CA
Core B - Biospecimen/Pathology Core
$256,386Iman Osman · New York University School Of Medicine · P50 · FY2020 · CA
Biostatistics and Bioinformatics Core
$256,385Phyllis A Gimotty · Wistar Institute · P50 · FY2021 · CA
TLR-mediated DC activation and immune reconstitution
$256,373Hong-Ming Hu · Providence Portland Medical Center · R01 · FY2006 · CA
REGULATION OF UVEAL MELANOMA INTERCONVERTED PHENOTYPE
$256,352University Of Iowa · R01 · FY2003 · CA
Use of Adjuvants to Improve Skin Genetic Immunizations
$256,287Adriana T Larregina · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · CA
Molecular Determinants of Androgen Receptor Function
$256,248Elizabeth M. Wilson · Univ Of North Carolina Chapel Hill · U54 · FY2010 · HD
The Role of Beta-catenin Signaling in Malignant Melanoma
$256,179Marcus W Bosenberg · University Of Vermont & St Agric College · R01 · FY2007 · CA
Project 3: Molecular Targets of Rexinoid Action in Skin
$256,177Natalia Y Kedishvili · University Of Alabama At Birmingham · P01 · FY2020 · CA
Neoantigen immunotherapy in brain tumors using anti-CD27 to deplete regulatory T cells selectively
$256,082John H Sampson · Duke University · P50 · FY2019 · CA
Imaging the Effects of Inhibition of Oncogene Signaling on Tumor Growth and Metabolism
$256,076Steven M Larson · Sloan-Kettering Inst Can Research · P50 · FY2015 · CA
Melanoma Cell Surface Proteoglycans in Metastasis
$256,070James B. McCarthy · University Of Minnesota · R01 · FY2007 · CA
Melanoma Cell Surface Proteoglycans in Metastasis
$256,070James B. McCarthy · University Of Minnesota · R01 · FY2009 · CA
Melanoma Cell Surface Proteoglycans in Metastasis
$256,070James B. McCarthy · University Of Minnesota · R01 · FY2010 · CA
Melanoma Cell Surface Proteoglycans in Metastasis
$256,070James B. McCarthy · University Of Minnesota · R01 · FY2008 · CA
FLK1 SINALING PROTECTS TUMOR VASCULATURE FROM RADIATION
$256,035Vanderbilt University · R01 · FY2001 · CA
Tyoloindicines--Potent Antitumor Compounds
$255,989University Of Tennessee Knoxville · R01 · FY2003 · CA
Integrated, Individualized, Intelligent Prescribing (I3P)
$255,979Joshua C. Denny · Vanderbilt University Medical Center · U01 · FY2016 · HG